Skip to main content
Jacob Abraham, MD, Cardiology, Portland, OR, Providence St. Vincent Medical Center

JacobAbrahamMD

Cardiology Portland, OR

Echocardiography, Heart Failure & Transplantation, Nuclear Cardiology, Non-Invasive Cardiology

Physician

Dr. Abraham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Abraham's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2004 - 2008
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2001 - 2004
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2001

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2009 - 2025
  • WA State Medical License
    WA State Medical License 2009 - 2012
  • MD State Medical License
    MD State Medical License 2005 - 2010
  • American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • After Rare and Serious Complication From COVID-19, Oregon Mom Is Back in Good Health
    After Rare and Serious Complication From COVID-19, Oregon Mom Is Back in Good HealthApril 14th, 2023
  • Hemodynamic Monitoring Benefit Affirmed for Seniors with HF
    Hemodynamic Monitoring Benefit Affirmed for Seniors with HFMay 15th, 2019
  • FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy
    FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or CardiomyopathyMay 13th, 2019

Hospital Affiliations